Specific packaging of spliced retroviral vector transcripts lacking the Ψ-region

Biochemical and Biophysical Research Communications

Volumn 293, Issue 1, 2002, Pages 239-246

  Pambalk, Konstanze ^a   Hohenadl, Christine ^b   Salmons, Brian ^b   Günzburg, Walter H ^a   Renner, Matthias ^b  

^a UNIVERSITY OF VETERINARY MEDICINE   (Austria)

^b Austria   (Austria)

Author keywords

Gene therapy; Packaging signal; Retroviral vector; Splicing; Titer

Indexed keywords

RETROVIRUS VECTOR; VIRUS RNA;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; EMBRYO; GENE THERAPY; HUMAN; HUMAN CELL; MOUSE; MURINE LEUKEMIA VIRUS; NONHUMAN; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA SPLICING; SEQUENCE ALIGNMENT; SOUTHERN BLOTTING; VIRUS GENOME; VIRUS TRANSCRIPTION;

ANIMALS; BASE SEQUENCE; BINDING SITES; CELL LINE; DNA PRIMERS; GENETIC VECTORS; GREEN FLUORESCENT PROTEINS; HELA CELLS; HUMANS; LEUKEMIA VIRUS, MURINE; LUMINESCENT PROTEINS; MICE; MOLECULAR SEQUENCE DATA; MUTAGENESIS, SITE-DIRECTED; POLYMERASE CHAIN REACTION; RETROVIRIDAE; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA SPLICING; TRANSCRIPTION, GENETIC;

MURINAE; MURINE LEUKEMIA VIRUS;

EID: 0036293432     PISSN: 0006291X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-291X(02)00207-3     Document Type: Article

References (34)

1. The use of DNA viruses as vectors for gene therapy
2. Gene therapy's growing pains
3. Redesign of retrovirus packaging cell lines to avoid recombination leading to helper virus production
4. Retrovirus packaging cells
5. Retroviral nucleocapsid domains mediate the specific recognition of genomic viral RNAs by chimeric Gag polyproteins during RNA packaging in vivo
6. Construction of a retrovirus packaging mutant and its use to produce helper-free defective retrovirus
7. Varying the position of a retrovirus packaging sequence results in the encapsidation of both unspliced and spliced RNAs
8. Deletion mutants of Moloney murine leukemia virus which lack glycosylated gag protein are replication competent
9. Improved retroviral vectors for gene transfer and expression
10. Evidence that the packaging signal of Moloney murine leukemia virus extends into the gag region
11. Effect of internal viral sequences on the utility of retroviral vectors
12. Identification of a signal in a murine retrovirus that is sufficient for packaging of nonretroviral RNA into virions
13. Presence of a retroviral encapsidation sequence in nonretroviral RNA increases the efficiency of formation of cDNA genes
14. cis-Active structural motifs involved in specific encapsidation of Moloney murine leukemia virus RNA
15. Effect of dimerization on the conformation of the encapsidation Psi domain of Moloney murine leukemia virus RNA
16. Pre-mRNA processing and mRNA nuclear export
17. High effeciency retroviral vectors that contain no viral coding sequences
18. Rapid identification of viable retrovirus-transduced cells using the green fluorescent protein as a marker
19. Characteristics of a human cell line transformed by DNA from human adenovirus type 5
20. Construction and use of a safe and efficient amphotropic packaging cell line
21. High-titer packaging cells producing recombinant retroviruses resistant to human serum
22. Tissue culture studies of the proliferative capacity of cervical carcinoma and normal epithelium
23. Murine sarcoma and leukemia viruses: Assay using clonal lines of contact-inhibited mouse cells
24. Increased levels of spliced RNA account for augmented expression from the MFG retroviral vector in hematopoietic cells
25. Construction of retroviral vectors with improved safety, gene expression, and versatility
26. A detailed model of reverse transcription and tests of crucial aspects
27. Retroviral RNA packaging: A review
28. A double hairpin structure is necessary for the efficient encapsidation of spleen necrosis virus retroviral RNA
29. Packaging of endogenous retroviral sequences in retroviral vectors produced by murine and human packaging cells
30. Split-intron retroviral vectors: Enhanced expression with improved safety
31. The dimerization/packaging sequence is dispensable for both the formation of high-molecular-weight RNA complexes within retroviral particles and the synthesis of proviruses of normal structure
32. Analysis of the relative level of gene expression from different retroviral vectors used for gene therapy